West Pharmaceutical rises after lifting annual profit forecast

West Pharmaceutical Services

23/10/2025 14:58

Updates

** Shares of medical equipment maker West Pharmaceutical Services WST.N rise 12.2% to $310

** WST lifts full-year adjusted EPS outlook to $7.06–$7.11 from $6.65–$6.85

** Co raises sales forecast to $3.06 bln–$3.07 bln from $3.04 bln–$3.06 bln

** Co reports Q3 adjusted EPS of $1.96 vs analysts' average estimate of $1.68, as per data compiled by LSEG

** WST's quarterly revenue of $804.6 mln beats Wall Street expectations of $787.9 mln

** Including session's move, stock down 2.6% YTD

 (Reporting by Sahil Pandey and Padmanabhan Ananthan in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))